title: The JNK binding domain of islet-brain 1 inhibits IL-1 induced JNK activity and apoptosis but not the transcription of key proapoptotic or protective genes in insulin-secreting cell lines.
abstract: The stress-activated protein kinase c-Jun NH2-terminal kinase (JNK) is a central signal for interleukin-1beta (IL-1beta)-induced apoptosis in insulin-producing beta-cells. The cell-permeable peptide inhibitor of JNK (JNKI1), that introduces the JNK binding domain (JBD) of the scaffold protein islet-brain 1 (IB1) inside cells, effectively prevents beta-cell death caused by this cytokine. To define the molecular targets of JNK involved in cytokine-induced beta-cell apoptosis we investigated whether JNKI1 or stable expression of JBD affected the expression of selected pro- and anti-apoptotic genes induced in rat (RIN-5AH-T2B) and mouse (betaTC3) insulinoma cells exposed to IL-1beta. Inhibition of JNK significantly reduced phosphorylation of the specific JNK substrate c-Jun (p<0.05), IL-1beta-induced apoptosis (p<0.001), and IL-1beta-mediated c-fos gene expression. However, neither JNKI1 nor JBD did influence IL-1beta-induced NO synthesis or iNOS expression or the transcription of the genes encoding mitochondrial manganese superoxide dismutase (MnSOD), catalase (CAT), glutathione peroxidase (GPx), glutathione-S-transferase rho (GSTrho), heat shock protein (HSP) 70, IL-1beta-converting enzyme (ICE), caspase-3, apoptosis-inducing factor (AIF), Bcl-2 or Bcl-xL. We suggest that the anti-apoptotic effect of JNK inhibition by JBD is independent of the transcription of major pro- and anti-apoptotic genes, but may be exerted at the translational or posttranslational level.
authors.affiliation: Steno Diabetes Center, DK-2820 Gentofte, Denmark
authors.forename: M A
authors.initials: MA
authors.lastname: Nikulina
authors.forename: N
authors.initials: N
authors.lastname: Sandhu
authors.forename: Z
authors.initials: Z
authors.lastname: Shamim
authors.forename: N A
authors.initials: NA
authors.lastname: Andersen
authors.forename: A
authors.initials: A
authors.lastname: Oberson
authors.forename: P
authors.initials: P
authors.lastname: Dupraz
authors.forename: B
authors.initials: B
authors.lastname: Thorens
authors.forename: A E
authors.initials: AE
authors.lastname: Karlsen
authors.forename: C
authors.initials: C
authors.lastname: Bonny
authors.forename: T
authors.initials: T
authors.lastname: Mandrup-Poulsen
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D001665:Binding Sites; D007328:Insulin / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism; D007515:Islets of Langerhans / Q000378:metabolism*; D048031:JNK Mitogen-Activated Protein Kinases; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase / Q000378:metabolism; D009687:Nuclear Proteins / Q000378:metabolism*; D017434:Protein Structure, Tertiary; D051381:Rats; D015534:Trans-Activators / Q000378:metabolism*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D007328:Insulin; D007375:Interleukin-1; C490665:Mapk8ip protein, mouse; C110528:Mapk8ip1 protein, rat; D009687:Nuclear Proteins; D015534:Trans-Activators; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases